Selective use of RAI for ablation and adjuvant therapy after total thyroidectomy for differentiated thyroid cancer: A practical approach to clinical decision making

This publication has 32 references indexed in Scilit:

• A Low Postoperative Nonstimulated Serum Thyroglobulin Level Does Not Exclude the Presence of Radioactive Iodine Avid Metastatic Foci in Intermediate-Risk Differentiated Thyroid Cancer Patients
  Thyroid®, 2013
• Clinical Outcomes Following Empiric Radioiodine Therapy in Patients with Structurally Identifiable Metastatic Follicular Cell–Derived Thyroid Carcinoma with Negative Diagnostic But Positive Post-Therapy ¹³¹ I Whole-Body Scans
  Thyroid®, 2012
• The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer
  Surgery, 2011
• Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients
  The Journal of Clinical Endocrinology & Metabolism, 2011
• Recombinant Human Thyrotropin in Thyroid Remnant Ablation with 131-Iodine in High-Risk Patients
  Thyroid®, 2010
• Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function
  Thyroid®, 2010
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
  Thyroid®, 2009
• Update to the College of American Pathologists Reporting on Thyroid Carcinomas
  Head and Neck Pathology, 2009
• Resistance of [ ¹⁸ F]-Fluorodeoxyglucose-Avid Metastatic Thyroid Cancer Lesions to Treatment with High-Dose Radioactive Iodine
  Thyroid®, 2001
• Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
  The Journal of Clinical Endocrinology & Metabolism, 2001